United States v. Steven Paul

CourtCourt of Appeals for the Seventh Circuit
DecidedNovember 29, 2018
Docket17-3606
StatusUnpublished

This text of United States v. Steven Paul (United States v. Steven Paul) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Steven Paul, (7th Cir. 2018).

Opinion

NONPRECEDENTIAL DISPOSITION To be cited only in accordance with Fed. R. App. P. 32.1

United States Court of Appeals For the Seventh Circuit Chicago, Illinois 60604

Argued November 15, 2018 Decided November 29, 2018

Before

WILLIAM J. BAUER, Circuit Judge

MICHAEL S. KANNE, Circuit Judge

AMY J. ST. EVE, Circuit Judge

No. 17-3606

UNITED STATES OF AMERICA, Appeal from the United States District Plaintiff-Appellee, Court for the Northern District of Illinois, Eastern Division. v. No. 1:11-cr-00580-2 STEVEN PAUL, Defendant-Appellant. Ronald A. Guzman, Judge.

ORDER

After Steven Paul pleaded guilty to healthcare fraud, he sought to withdraw his plea on two grounds. First, he argued that the government had offered him immunity in exchange for his cooperation. Second, he contended that, because of the supposed agreement not to prosecute, his lawyers were ineffective for allowing the prosecution to proceed. The district court denied his motion. It ruled that the government had never promised immunity and Paul’s lawyers had rendered adequate counsel. Because the record supports these findings, the denial of the motion to withdraw was a permissible No. 17-3606 Page 2

exercise of discretion. We thus reject Paul’s challenge to the district court’s ruling and affirm the judgment.

Background

Paul jointly owned and operated chiropractic clinics in the suburbs of Chicago. The government investigated Paul and others for using these clinics to bill Blue Cross/Blue Shield fraudulently for services that were either medically unnecessary or never actually provided. The insurance company was defrauded into paying Paul’s clinics approximately $1.3 million.

After federal agents contacted Paul in February 2009 about the investigation, his defense team sought over the next six years to obtain immunity or other relief from prosecution in exchange for Paul’s cooperation with the government. These extended attempts are reflected in correspondence, affidavits, and testimony presented to the district court, which are recounted below.

Paul testified that the government never gave him a written immunity deal or told him personally, “you [are] getting immunity.” But during their years of negotiations, Paul’s attorneys repeatedly assured him that he could receive immunity for his cooperation. With cooperation in mind, in April 2009 Paul signed an agreement with federal prosecutors. It provided that in exchange for Paul’s truthful proffer of information, the proffer would not be used against him in a later prosecution. The agreement, however, allowed the government to prosecute Paul if his proffer led to the discovery of new evidence against him: “The government is completely free to pursue any and all investigative leads derived in any way from the proffer, which could result in the acquisition of evidence admissible against your client.” The letter concluded: “This letter embodies the entirety of the agreement to make a proffer. No other promise or agreement exists between you or this office regarding the proffer.”

Paul’s cooperation continued, and six months later, in October 2009, he and his defense team met with the government to prepare Paul’s statement to a grand jury. The meeting became contentious: Paul still wanted immunity in return for his testimony, but the Assistant United States Attorney (AUSA) offered only to defer prosecution. The AUSA’s “draft” proposal to defer prosecution lacked signatures, a specified amount of restitution, and details of what Paul would admit. According to one of Paul’s lawyers, after the defense team fumed at the perceived discrepancy between their discussions No. 17-3606 Page 3

and the AUSA’s offer, the AUSA “apologized” and “realized that offer was not what had been promised.”

After the meeting, Paul and the defense team reviewed their options. They discussed the import of a deferred-prosecution agreement. One lawyer described it as “prosecutor’s probation”; if Paul met its terms, he would not be prosecuted. The lawyer advised him to reject the deferred-prosecution proposal and hold out for immunity. Paul did so and continued to assist the government’s investigation. According to Paul’s lawyer, the AUSA was encouraging: the AUSA said that a discussion about “immunity was back on track.” The defense team thought that one obstacle to concluding an immunity deal was Paul’s refusal to pay restitution, so in May 2010 Paul gave $150,000 to Blue Cross/Blue Shield and received a release.

But an immunity deal never materialized. In frustration, a year later, in June 2011, one of Paul’s lawyers wrote to the AUSA to review the chronology of the fluctuating conversations about immunity. According to the lawyer, in 2009 the government stated that it “cannot guarantee immunity.” Then, in January 2010, the lawyer thought that “the government might immunize Dr. Paul.” Later, in June 2010 (after Paul’s $150,000 payment), the government reported “second thoughts about Dr. Paul’s restitution.” Finally, in April 2011, the defense team “was caught off guard” when the government asked, “Why is Dr. Paul deserving of immunity?” Paul’s lawyer implored the government to consider Paul’s cooperation “as it weighs the prosecutorial decision.” The government, however, never changed its position on refusing to grant immunity.

Paul’s strategy changed in the fall of 2011. One of his lawyers had asked the government to revive the deferred-prosecution offer, but the prosecutor declined. With his options diminished, Paul signed a plea letter. The letter provided that Paul would plead guilty to one count of healthcare fraud and the government would recommend that the court sentence Paul below the applicable guidelines range.

A year later, in 2012, Paul entered a formal plea agreement and pleaded guilty to one count of healthcare fraud. At the change-of-plea hearing, he swore that he was fully satisfied with his attorneys’ advice and representation, had read the written plea agreement, understood its terms, and entered into it voluntarily. The signed plea agreement “represent[ed] the entire understanding that [he] had with the government about [his] guilty plea,” and no one had made any other promises to him inducing him to plead guilty. No. 17-3606 Page 4

Over the next two years, Paul’s lawyers tried still to avoid prosecution. They renewed their request for deferred prosecution, but the government again declined to offer it and stood by the plea agreement. With new counsel in May 2015, Paul tried a new strategy. He asked for a “Kastigar-Palumbo” hearing and to withdraw his plea. In Kastigar v. United States, 406 U.S. 441 (1972), the Court ruled that when the government prosecutes someone after granting that person use or derivative-use immunity, the Fifth Amendment requires a hearing to determine if the government’s evidence came from an independent source. In United States v. Palumbo, 897 F.2d 245 (7th Cir. 1990), we ruled that informal grants of immunity also necessitate a Kastigar hearing. Paul raised two arguments in his motion. First, he contended that because (in his view) the government had promised him transactional immunity for his cooperation, he should be allowed to withdraw his guilty plea. Second, Paul maintained that he had received ineffective assistance of counsel, so his plea was involuntary. He complained that his former attorneys should have used the immunity deal to challenge his indictment and that they did not inform him about or explain the deferred-prosecution offer.

The district court granted Paul partial relief.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kastigar v. United States
406 U.S. 441 (Supreme Court, 1972)
Blackledge v. Allison
431 U.S. 63 (Supreme Court, 1977)
Cleveland v. Policy Management Systems Corp.
526 U.S. 795 (Supreme Court, 1999)
United States v. Raymond J. Lyons
670 F.2d 77 (Seventh Circuit, 1982)
United States v. William R. Palumbo
897 F.2d 245 (Seventh Circuit, 1990)
United States v. Scott Sophie
900 F.2d 1064 (Seventh Circuit, 1990)
United States v. John Weaver, Thomas D. Sikes
905 F.2d 1466 (Eleventh Circuit, 1990)
United States v. Eugene J. Cahill, Sr.
920 F.2d 421 (Seventh Circuit, 1990)
United States v. Sidney Springs
988 F.2d 746 (Seventh Circuit, 1993)
Missouri v. Frye
132 S. Ct. 1399 (Supreme Court, 2012)
United States v. James M. Eliason
3 F.3d 1149 (Seventh Circuit, 1993)
United States v. Frank Fuzer
18 F.3d 517 (Seventh Circuit, 1994)
Manu Patel v. United States
19 F.3d 1231 (Seventh Circuit, 1994)
United States v. Larry Purnell
701 F.3d 1186 (Seventh Circuit, 2012)
United States v. Middlebrook
553 F.3d 572 (Seventh Circuit, 2009)
Economy Folding Box Corp. v. Anchor Frozen Foods Corp.
515 F.3d 718 (Seventh Circuit, 2008)
United States v. Christopher Jansen
884 F.3d 649 (Seventh Circuit, 2018)
United States v. Graf
827 F.3d 581 (Seventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Steven Paul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-steven-paul-ca7-2018.